Matthew Hawryluk's Net Worth

$635 Thousand

Estimate Recalculated Apr 12, 2024 04:28PM EST

Who is Matthew Hawryluk?

Matthew Hawryluk does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include Predictive Oncology Inc., and Gritstone bio, Inc..

SEC CIK

Matthew Hawryluk's CIK is 0001754470

Past Insider Trading and Trends

2023 was Matthew Hawryluk's most active year for acquiring shares with 5 total transactions. Matthew Hawryluk's most active month to acquire stocks was the month of January. 2023 saw Matthew Hawryluk paying a total of $0.00 for 234,251 shares, this is the most they've acquired in one year.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

Predictive Oncology Inc. (POAI) Snapshot price: $2.96

Investor

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+33.26%
2.37K
—
—
9.49K
Apr 5
Form 4
+35.65%
1.88K
—
—
7.13K
Oct 2
Form 4
+103.48%
2.67K
—
—
5.26K
Jul 3
Form 4
+55.08%
18.36K
—
—
51.69K
Apr 3
Form 4
+142.20%
19.57K
—
—
33.33K
Jan 3
Form 4
∞
13.76K
—
—
13.76K
Dec 1
Form 3
—
0
—
—
0
No matching records found

Gritstone bio, Inc. (GRTS) Snapshot price: $2.14

EVP, CHIEF BUSINESS OFFICER

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+13.90%
35K
—
—
286.88K
Feb 1
Form 4
+339.18%
191.77K
—
—
248.31K
Feb 2
Form 4
+68.09%
21.61K
—
—
53.35K
Jan 31
Form 4
+426.27%
19.6K
—
—
24.2K
Jan 7
Form 4
—
0
—
—
0
Mar 8
Form 4
—
0
—
—
0
Feb 25
Form 4
—
0
—
—
0
Feb 13
Form 3
—
0
—
—
0
No matching records found